Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis

Infection and Immunity

Volumn 69, Issue 2, 2001, Pages 949-958

  Adamou, J E ^a   Heinrichs, J H ^a   Erwin, A L ^a   Walsh, W ^a   Gayle, T ^a   Dormitzer, M ^a   Dagan, R ^a   Brewah, Y A ^a   Barren, P ^a   Lathigra, R ^a   Langermann, S ^a   Koenig, S ^a   Johnson, S ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; HISTIDINE; VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HYDROPHOBICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; SEPSIS; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTEREMIA; BACTERIAL PROTEINS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 0035143948     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.2.949-958.2001     Document Type: Article

References (39)

1. Lipoproteins, structure, function, biosynthesis and model for protein export
2. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae
3. PspA and PspC: Their potential for use as pneumococcal vaccines
4. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: Implications for development of a conjugate vaccine
5. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Surveilance System
6. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations
7. Epidemiology of invasive childhood pneumococcal infections in Israel
8. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants
9. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases
10. Antibody response to pneumococcal vaccination in children younger than five years of age
11. Vaccination against Streptococcus pneumoniae in childhood: Lack of demonstrable benefit in young Australian children
12. The microbiology of otitis media
13. Clinical and epidemiological studies of pneumococcal infection in children
14. Role of positive charge on the amino-terminal region of the signal peptide in protein secretion across the membrane
15. New vaccines for the prevention of pneumococcal infections
16. The epidemiology of pneumococcal disease in infants and children
17. Pneumococcal disease and the role of conjugate vaccines
18. Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines
19. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
20. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination
21. Structure-based analysis of catalysis and substrate definition in the HIT protein family
22. Vaccination against colonizing bacteria with multiple serotypes
23. Predicting coiled coils from protein sequences
24. Nucleotide sequence of Acinetobacter baumannii aphA-6 gene: Evolutionary and functional implications of sequence homologies with nucleotide-binding proteins, kinases and other aminoglycoside-modifying enzymes
25. PspA, a surface protein of Streptococcus pneumoniae, is capable of eiiciting protection against pneumococci of more than one capsular type
26. Membrane topology of Escherichia coli prolipoprotein signal peptidase (signal peptidase II)
27. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
28. Penicillin tolerance genes of Streptococcus pneurnoniae: The ABC-type manganese permease complex Psa
29. The complete secretory pathway in gram-negative bacteria
30. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae
31. Protective efficacy of polyvalent pneumococcal polysaccharide vaccine
32. The 3′-terminal sequence of Escherichia coli 16S ribosomal RNA: Complementarity to nonsense triples and ribosome binding sites
33. Pneumococcal disease: Prospects for a new generation of vaccines
34. Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin
35. Lipoproteins of gram-positive bacteria
36. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA)
37. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene
38. The structure of signal peptides from bacterial lipoproteins